Phase III Human Trials Begin

Phase III Human Trials Begin

Building on the success of the first two human trails of the CGCI platform in Madrid, Spain, a 54 patient Phase III Trial is conducted to perform standard atrial as well as paroxysmal atrial ablations. The goal of the study was to perform a series of atrial ablation...
First-In-Man Clinical Trials For CGCI Completed

First-In-Man Clinical Trials For CGCI Completed

The key benefits and the safety and effectiveness of the CGCI system have been further validated in a 40-patient human study that was recently completed under the direction of Dr. Jose Luis Merino Llorens, Director of the Arrhythmia–Electrophysiology Research Unit at...
Dr. Eli Gang Ranked Among America’s Best Doctors

Dr. Eli Gang Ranked Among America’s Best Doctors

Dr. Eli Gang, M.D., Chief Operating Officer of Neuro-Kinesis and Clinical Professor of Medicine, Geffen School of Medicine at UCLA, was ranked among America’s Top Doctors® according to a peer survey conducted by U.S. News & World Report magazine In the recently...
CGCI Presented to International Congress

CGCI Presented to International Congress

At the 2011 EHRA Europace Congress in Madrid, Spain, Dr. Jose Merino, Director of the Arrhythmia–Electrophysiology Research Unit at Hospital Universitario La Paz in Madrid was asked to host a Live-Case presentation of the CGCI system. The presentation consisted of a...